MANTLE CELL LYMPHOMA
FDA gives second approval to Eli Lilly's drug for type of blood cancer
Eli Lilly said the health regulator gave the new approval to the drug for the treatment of chronic lymphocytic leukemia (CLL), a type of cancer in which the bone marrow makes too many of certain white blood cells. Jaypirca was first given accelerated approval by the FDA on Jan. 27 for the treatment of mantle cell lymphoma.
Discovery suggests new way to target mantle cell lymphoma
The discovery in the Journal of Clinical Investigation, could lead to new mantle cell lymphoma drugs as well as a better understanding of how this type of lymphoma develops.
Gland Pharma launches generic cancer treatment drug in US
The Hyderabad-based company said its product is therapeutically equivalent to Takeda Pharmaceuticals' Velcade for Injection.
Zydus Lifesciences gets USFDA's nod to market generic version of Bortezomib
The drug, a generic version of reference listed drug Velcade, will be manufactured at Zydus Hospira, Gujarat.
Buy Natco Pharma, target price Rs 1021: ICICI Securities
Natco Pharma Ltd., incorporated in the year 1981, is a Mid Cap company (having a market cap of Rs 15529.31 Crore) operating in Pharmaceuticals sector.
Stocks in the news: Tata Motors, L&T, Dish TV, Ashok Leyland and Natco Pharma
Tata Motors said it has bagged a contract for 65 electric vehicles from Kerala State Electricity Board. The order includes 60 Tigor EVs and 5 Nexon EV SUVs.
- Go To Page 1
Natco Pharma announces launch of first generic of top selling cancer drug Revlimid
Revlimid had annual sales of $2.3 billion as of December 2021, according to IQVIA data. The generic version of Revlimid will be available in 5mg, 10mg, 15mg, and 25mg strengths. The announcement came after market hours. The Shares of Natco Pharma 2.98% to close at Rs 844.30 on BSE on Monday, the benchmark Sensex fell 2.74% to end at 52,842.75 points.
Zydus Cadila gets tentative nod from USFDA to market cancer drug
"Ibrutinib belongs to a class of drugs known as kinase inhibitors and is used to treat certain cancers, such as mantle cell lymphoma or marginal zone lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, and Waldenstrom's macroglobulinemia," Zydus Cadila said.
Natco Pharma shares hit upper circuit. Here's why
The Hyderabad-based firm said the first dose under the phase-III trials was given to a patient in the city-based Yashoda Hospitals.
Stocks in the news: Grasim, SBI, JSW Steel, Dr Reddy's Labs, India Cements and Natco Pharma
The country's largest lender reported an 80.15 per cent jump in its standalone profit after tax (PAT) of Rs 6,451 crore in the three months to March 2021.
Natco Pharma gets American drug regulator's nod for generic cancer treatment drug
Natco, along with its marketing partner Arrow International previously settled the Paragraph IV litigation related to the product with Celgene, now part of Bristol-Myers Squibb, who sells the product under the brand name 'Revlimid', it added.
Zydus Cadila gets USFDA nod for cancer and high blood pressure, treatment drug
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Ibrutinib Capsules in the strengths of 70 mg and 140 mg, Cadila Healthcare said in a regulatory filing.
Bernie Madoff's son, Andrew leaves over $15 million to family
Ponzi scheme fraudster Bernie Madoff's son, Andrew along with his late brother Mark, exposed their father's fraud.
Load More
